Skip to main content

ESMINT Members’ Newsletter – First Edition

24 Dec 2022   Category/ies: Society

Dear ESMINT Members & Friends,

Welcome to this first issue of the ESMINT members’ newsletter!

Below you’ll find a welcome note from the ExBoard, exciting news about our annual congress as well as our dedicated network, an update on ECMINT and information about current ESMINT surveys.

Welcome from the ExBoard

Thanks for being part of our society!

The aim of this newsletter is to ensure that you – our fellow ESMINT members – are the first to hear about projects, research, upcoming events and other updates.

You are warmly invited to send in articles and topics for inclusion and suggestions!

ESMINT ExBoard: Dr. Kulcsar, Dr. Januel and Dr. Taschner.

We look forward keeping connected with you.

The ESMINT Congress

Goodbye Nice, Hello Marseille!

After 14 years in Nice, it’s been necessary to find another venue, and we are delighted to be heading to Le Palais du Pharo in Marseille in September 2023!

Le Palais du Pharo offers a state-of-the-art venue in an ideal location, where we can come together and share the most up-to-date scientific and technological developments, renew connections with colleagues and build new alliances to further advance our field.

Palais du Pharo in Marseille.

Calendar alert!
In 2023, the ESMINT Congress – exceptionally – will take place from a Monday to a Wednesday. The dates are 4th to 6th September 2023.

The ESMINT 2023 team:

  • Congress President: Paolo Machi (Switzerland)
  • Congress Vice-Presidents: Mohamed Aggour (UK) and Anne Christine Januel (France)

We look forward to welcoming you to the beautiful city of Marseille in September 2023!

Siilo – ESMINT’s dedicated network

Discuss cases with colleagues on a secure platform

Siilo is a secure medical messaging app designed to help healthcare professionals collaborate on difficult cases, improve patient care, and share knowledge in a compliant way. It is simple and intuitive to use.

ESMINT has a dedicated, members-only space within the app where you can connect with fellow ESMINT members and give and receive insights and advice, and keep up to date with ESMINT news.

ESMINT's Siilo App


European Course in Minimally Invasive Neurological Therapy

The fourth course of the fourth cycle of ECMINT took place 12-16 December at St Anne’s College, Oxford. The main topics was Endovascular Treatment of Arteriovenous Malformations and Fistulas.

93 participants attended in person and a further 34 joined virtually. Our in-person attendees came from all over Europe – 24 European countries were represented – with others from as far afield as Argentina and Hong Kong.

Despite various challenges including a faulty heating system (coupled with very cold weather!) and a series of public transport strikes in the UK, the course was a great success.

A massive thank you to all of our stellar faculty and to the course directors Adam Rennie, Phil White, and Peter Jezzard – and former course director Shelley Renowden, who is still involved as faculty. Big thanks also to Tarryn Ching and Charlotte Tai from Oxford University who did a great job as usual. Finally, our thanks to the team at St Anne’s and our course dinner venue, Oriel College.

To find out more about ECMINT, please visit our website. The fifth cycle of the course will start in June 2023.

Scientific surveys

Share your experiences!

You are invited to participate in our current surveys. These allow ESMINT better to serve and advocate for members in our field of neurointerventions.

We thank you in advance for any feedback you are able to share.

Survey #1: Evidence base for medical devices in interventional neuroradiology

The goal of this survey is to get an impression of your personal expectations regarding the evidence base for class III medical devices (highest risk group, e.g. implantable devices such as stents, flow diverters, intrasaccular devices) used in endovascular neurointerventions.

Survey #2: Heparin use in stroke thrombectomy

This survey is designed to obtain more insight in the use of heparin during EVT among European interventionists.

We welcome all feedback, comments and questions you may have, and suggestions of topics you’d like to see in future newsletters. Please also send in anything you would like to share in the newsletter (e.g. surveys, job opportunities, fellowships).

We wish you all a wonderful Seasonal Break and a Happy 2023!

Zsolt Kulcsar
Anne Christine Januel
Christian Taschner
The ESMINT Office team